GlassScriptPhysician profile
James H Carraway
NPI 1578536967
$4,099.19
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $2,848 · 2021: $485 · 2022: $371 · 2023: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $2,805.07 | 2019-2021 | |
| Sientra, INC. | $221.87 | 2020-2022 | |
| Mentor Worldwide LLC | $188.72 | 2021-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $154.92 | 2019-2022 | |
| Abbvie INC. | $100.93 | 2021-2022 | |
| Integra Lifesciences Corporation | $88.89 | 2020-2023 | Durasorb Monofilament Mesh |
| Galderma Laboratories, L.P. | $81.37 | 2020-2022 | |
| Checkpoint Surgical, INC | $71.40 | 2021 | |
| Allergan, INC. | $55.56 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $51.33 | 2020-2022 | |
| Acell, INC. | $47.32 | 2019-2020 | |
| Avita Medical Americas, LLC | $44.62 | 2023 | Recell |
| Kerecis Limited | $42.89 | 2019 | |
| Bioventus LLC | $32.92 | 2022 | |
| Misonix INC | $29.48 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Biosciences INC | $22.36 | 2019 | |
| Medela LLC | $21.61 | 2022 | |
| Polynovo North America LLC | $21.31 | 2021 | |
| Polarityte, INC. | $16.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Carraway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.